跳至主要内容
临床试验/NCT03914157
NCT03914157撤回不适用

Ultrasound Wave Therapy for Post-stenotic Microvascular Remodeling

Mayo Clinic0 个研究点开始时间: 2023年3月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
发起方
Mayo Clinic
主要终点
Change in renal fibrosis assessed by MRI

研究概览

简要总结

Researchers are evaluating a noninvasive treatment with ultrasound waves for Atherosclerotic Renal Artery Stenosis (ARAS).

详细描述

Investigators will study 30 patients with ARAS randomized to SWT or sham (n=15 each) twice a week over 3 weeks. We will measure before and again 3 months after a 3-wk regimen renal cortical and medullary perfusion and function (multi-detector computed tomography [MDCT]), oxygenation, and fibrosis (magnetic resonance imaging [MRI]), urinary and plasma levels of renal injury markers, systemic endothelial function, and heart rate variability, an index of sympathetic activation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
40 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Change in renal fibrosis assessed by MRI

时间窗: Baseline, 3 months

Renal fibrosis as determined by Magnetization transfer imaging (MTI)-MRI in vivo.

Change in kidney perfusion assessed by computed tomography

时间窗: Baseline, 3 months

Single-kidney perfusion and GFR assessed by multi-detector computed tomography (MDCT)

Change in blood oxygen in kidney assessed by MRI

时间窗: Baseline, 3 months

Cortical and medullary oxygenation assessed by Blood oxygen-level-dependent (BOLD)-MRI

Change in renal function assessed by GFR

时间窗: Baseline, 3 months

Renal function by eGFR calculated by both the modified modification of Diet in Renal Disease (MDRD) formula, and measured GFR (mGFR) by iothalamate clearance

Change in labs collected from right and left renal veins and/or Inferior Vena Cava

时间窗: Baseline, 3 months

Serum creatinine, plasma renin activity (PRA), aldosterone, cytokines and circulating endothelial progenitor cell (EPC) in blood collected from the left and right renal veins and the Inferior Vena Cava (IVC).

Change in urinary levels of biomarkers and extracellular vehicles

时间窗: Baseline, 3 months

Urinary biomarkers albumin, renal injury markers: Neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecular (KIM)-1, and lactate dehydrogenase (LDH)\], as well as urinary levels of extracellular vehicles (EVs) (measured by flow cytometry) originating from renal microvessels.

Change in mean arterial pressure assessed by oscillometry

时间窗: Baseline, 3 months

systolic and diastolic BP will be measured by oscillometry to calculate MAP, and assessment of sympathetic nervous system activation by heart rate variability (HRV).

Change in peripheral microvascular endothelial function assessed in the fingertip

时间窗: Baseline, 3 months

Peripheral microvascular endothelial function by peripheral arterial tonometry (EndoPAT).

次要结局

未报告次要终点

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Rajiv Gulati

Principal Investigator

Mayo Clinic

相似试验